Anti-eIF4EBP1 (phospho T37 + T46) antibody [4EB1T37T46-A5]
- 20ul selling size
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal eIF4EBP1 phospho T37 + T46 antibody. Suitable for Flow Cyt, WB, IHC-P and reacts with Rat, Human, Mouse samples. Cited in 5 publications. Immunogen corresponding to Synthetic Peptide within Human EIF4EBP1 phospho T37 + T46.
View Alternative Names
Eukaryotic translation initiation factor 4E-binding protein 1, 4E-BP1, eIF4E-binding protein 1, Phosphorylated heat- and acid-stable protein regulated by insulin 1, PHAS-I, EIF4EBP1
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-eIF4EBP1 (phospho T37 + T46) antibody [4EB1T37T46-A5] (AB278686)
Peptide blocking flow cytometric analysis of Jurkat cells LY294002 plus wortmannin plus U0126 LWU) treated cells stained with secondary antibody as negative control (light blue) or treated with LWU (red) or treated with FBS (green) or LUW and blocked with phospho-peptide (black) or FBS and blocked with phospho peptide (gold) or LUW and blocked with non-phospho peptide (dark blue) or FBS and blocked with non-phospho peptide (purple) using ab278686 at 0.1μg/mL.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-eIF4EBP1 (phospho T37 + T46) antibody [4EB1T37T46-A5] (AB278686)
Flow cytometric analysis of Jurkat cells secondary antibody only negative control (blue) or treated with LY294002 + U0126 + wortmanmin (red) or with FBS (green) using 0.1 ug/mL of ab278686.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-eIF4EBP1 (phospho T37 + T46) antibody [4EB1T37T46-A5] (AB278686)
Flow cytometric analysis of C6 cells untreated cells stained with secondary antibody as negative control (blue) or untreated (red) or treated with UV and TPA (green) and stained using ab278686 at 0.1µg/mL.
- WB
Supplier Data
Western blot - Anti-eIF4EBP1 (phospho T37 + T46) antibody [4EB1T37T46-A5] (AB278686)
All lanes:
Western blot - Anti-eIF4EBP1 (phospho T37 + T46) antibody [4EB1T37T46-A5] (ab278686) at 0.001 µg/mL
Lane 1:
K562 cell extract untreated
Lane 2:
K562 cell extract treated with imatinib
Predicted band size: 13 kDa
false
- WB
Supplier Data
Western blot - Anti-eIF4EBP1 (phospho T37 + T46) antibody [4EB1T37T46-A5] (AB278686)
All lanes:
Western blot - Anti-eIF4EBP1 (phospho T37 + T46) antibody [4EB1T37T46-A5] (ab278686) at 0.001 µg/mL
Lane 1:
NIH3T3 cell extract untreated
Lane 2:
NIH3T3 cell extract treated with PDGF
Predicted band size: 13 kDa
false
Reactivity data
Product details
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF4EBP1 plays an important role in regulating cell growth and proliferation by modulating protein synthesis. It is a part of the eIF4F complex which is responsible for the initiation of mRNA translation. When hypophosphorylated eIF4EBP1 binds tightly to eIF4E and prevents the assembly of the active eIF4F complex leading to reduced translation initiation of mRNAs involved in growth and survival. This regulation is important in conditions where cells need to adapt to metabolic stress or external signals.
Pathways
The mammalian target of rapamycin (mTOR) pathway regulates eIF4EBP1 through phosphorylation. In response to growth signals mTOR phosphorylates eIF4EBP1 causing the release of eIF4E and allowing mRNA translation to proceed. This interaction links eIF4EBP1 to the PI3K/AKT/mTOR signaling pathway which influences cell cycle progression and survival. Related proteins in this pathway include ribosomal protein S6 kinase (S6K1) which is also phosphorylated by mTOR to promote protein synthesis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Cancer cell international 25:122 PubMed40158101
2025
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy 20:505-524 PubMed37772772
2023
Applications
Unspecified application
Species
Unspecified reactive species
Neural regeneration research 19:642-649 PubMed37721296
2023
Applications
Unspecified application
Species
Unspecified reactive species
Pain research & management 2023:8870256 PubMed37397163
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:581 PubMed33850553
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com